Contact
Please use this form to send email to PR contact of this press release:
EULAR 2020: Lilly’s TALTZ® (ixekizumab) Continues to Show Robust and Consistent Efficacy in Psoriatic Arthritis
TO:
Please use this form to send email to PR contact of this press release:
EULAR 2020: Lilly’s TALTZ® (ixekizumab) Continues to Show Robust and Consistent Efficacy in Psoriatic Arthritis
TO: